Genomic Testing Cooperative

Genomic Testing Cooperative provides comprehensive genomic profiling services using next-generation sequencing of both DNA and RNA to support cancer diagnosis, prognosis, therapy selection, and disease monitoring. Their tests are validated for clinical use with Medicare approval in the US as well as CE-IVD marking for Europe and UKCA marking for the UK. The company’s proprietary informatics tools leverage artificial intelligence to deliver rapid insights into patient tumor biology. GTC’s cooperative business model enables smaller labs to access advanced genomics without high overhead costs. The company has demonstrated double-digit growth with a rapidly expanding international footprint.